Product Name: BCL7B Antibody
Species Reactivity: Human, Mouse
Tested Applications: IHC-P, WB
Applications: For WB starting dilution is: 1:1000For IHC-P starting dilution is: 1:10~50
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 22 kDa
Immunogen: This BCL7B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 137-164 amino acids from the C-terminal region of human BCL7B.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 53963-43-2
Product: Ginsenoside F1
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.35 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: B-cell CLL/lymphoma 7 protein family member B, Hom s 3, BCL7B
Accession NO.: Q9BQE9
Protein Ino:
Official Symbol: BCL7B
Geneid: 9275
Background: This gene encodes a member of the BCL7 family includingBCL7A, BCL7B and BCL7C proteins. This member is BCL7B, whichcontains a region that is highly similar to the N-terminal segmentof BCL7A or BCL7C proteins. The BCL7A protein is encoded by thegene known to be directly involved in a three-way genetranslocation in a Burkitt lymphoma cell line. This gene is locatedat a chromosomal region commonly deleted in Williams syndrome. Thisgene is highly conserved from C. elegans to human. Multiplealternatively spliced transcript variants have been found for thisgene.
PubMed ID:http://aac.asm.org/content/53/12/5039.abstract
